BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12922)

  • 21. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
    Schiele BC
    Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
    Mattke DJ; Mombour W; Glötzner FL
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):36-44. PubMed ID: 788001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neurotic anxiety.
    Versiani M; Bueno JR; Mundim FD; da Silva JA; Rocha AV
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):701-15. PubMed ID: 825357
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of gradual decrease and discontinuation of neuroleptics on clinical condition and tardive dyskinesia [proceedings].
    Branchey MH; Branehey LB; Richardson MA
    Psychopharmacol Bull; 1981 Jan; 17(1):118-20. PubMed ID: 7232639
    [No Abstract]   [Full Text] [Related]  

  • 25. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 26. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
    Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
    J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of loxapine succinate as an anxiolytic in comparison with chlordiazepoxide.
    Mahal AS; Malik SC; Srinivasamurthy U
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):84-93. PubMed ID: 821710
    [No Abstract]   [Full Text] [Related]  

  • 28. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
    Kiloh LG; Williams SE; Grant DA; Whetton PS
    J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loxapine (Loxitane).
    Med Lett Drugs Ther; 1975 Dec; 17(25):103. PubMed ID: 1105124
    [No Abstract]   [Full Text] [Related]  

  • 34. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
    Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
    [No Abstract]   [Full Text] [Related]  

  • 35. Loxapine update: 1966-1976.
    Ayd FJ
    Dis Nerv Syst; 1977 Nov; 38(11):883-7. PubMed ID: 410614
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.